National patterns and predictors of liver biopsy use for management of hepatitis C
โ Scribed by Erik J. Groessl; Lin Liu; Samuel B. Ho; Fasiha Kanwal; Allen L. Gifford; Steven M. Asch
- Book ID
- 116652772
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 774 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
For patients who receive a liver transplant (LTX) for alcoholic liver disease (ALD), investigators are focusing beyond survival to determine specific alcohol use outcomes. Studies suggest the use of alcohol ranges from 8 to 22% for the first posttransplant year with cumulative rates reaching 30 to 4
End-stage liver disease secondary to hepatitis C virus (HCV) infection is the leading indication for liver transplantation in the United States. Recurrence of HCV infection is nearly universal. We studied the patients enrolled in the National Institute of Diabetes and Digestive and Kidney Diseases L